GW-274150

SynDRA canonical compound SYN0004182 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	NOS2
Mechanism of action	nitric oxide synthase inhibitor

All known targets

NOS2

Mechanisms of action (all sources)

NOS2 INHIBITOR
Nitric oxide synthase, inducible inhibitor
nitric oxide synthase inhibitor
NOS2 MODULATOR

Cross-references

PubChem CID: 9797017
ChEMBL: CHEMBL114551
DrugBank: DB12237
TTD: D05QJT

Synonyms

GW274150
UNII-0ZZF1V8G63
0ZZF1V8G63
CHEMBL114551
SCHEMBL120693
L-Homocysteine, S-(2-((1-iminoethyl)amino)ethyl)-
GTPL9849
ZINC2004483
BDBM50086467
AKOS030526714
DB12237
CS-5419
HY-12119
GW-274150;GW 274150
[2-[(1-iminoethyl) amino]ethyl]-L-homocysteine
(S)-4-(2-Acetimidoylamino-ethylsulfanyl)-2-amino-butyric acid
(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid
RefChem:1098212
S-(2-((1-Iminoethyl)amino)ethyl)-L-homocysteine
orb1709511
SCHEMBL26908440
EX-A7835
T11518L
DA-63978
NS00068789
H68140

Look up GW-274150 in the interactive SynDRA portal →